BNP Paribas Asset Management
TYRA icon

BNP Paribas Asset Management’s Tyra Biosciences TYRA Stock Holding History

BNP Paribas Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.94M Sell
128,860
-919
-0.7% -$29.8K 0.01% 860
2025
Q4 		$3.41M Buy
+129,779
New +$2.38M ﹤0.01% 932

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BNP Paribas Asset Management's TYRA Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Tyra Biosciences (TYRA) stake by 0.71% in Q1 2026, selling an estimated $29.8K and leaving 128,860 shares worth $4.94M. The position accounts for 0.01% of the portfolio, ranked #860.

BNP Paribas Asset Management first reported a position in TYRA in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • BNP Paribas Asset Management held 128,860 shares of Tyra Biosciences worth $4.94M as of Q1 2026.
  • BNP Paribas Asset Management sold 919 Tyra Biosciences shares in Q1 2026, an estimated $29.8K.
  • Tyra Biosciences made up 0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #860 holding.
  • BNP Paribas Asset Management first reported a position in Tyra Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.